BFM
GSK icon

Boothbay Fund Management’s GSK GSK Stock Holding History

Boothbay Fund Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-225,800
Closed -$8.05M – 1870
2023
Q2 		$8.05M Buy
225,800
+12,200
+6% +$438K 0.18% 107
2023
Q1 		$7.6M Sell
213,600
-68,600
-24% -$2.4M 0.16% 125
2022
Q4 		$9.92M Buy
+282,200
New +$9.4M 0.23% 64

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Boothbay Fund Management's GSK Position: Q2 2026 in Review

Boothbay Fund Management opened a new position in GSK (GSK) in Q2 2026: 156,400 shares worth $8.2M. The stake represents 0.11% of the portfolio and ranks #204 among its holdings. This is a return to the name: Boothbay Fund Management previously reported a position in GSK as recently as Q2 2025.

Boothbay Fund Management first reported a position in GSK in Q3 2021 and has held it in 12 quarters since. The position peaked at $29.7M in Q2 2023. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Boothbay Fund Management held 156,400 shares of GSK worth $8.2M as of Q2 2026.
  • GSK was a new Boothbay Fund Management position in Q2 2026.
  • GSK made up 0.11% of Boothbay Fund Management's portfolio in Q2 2026, its #204 holding.
  • Boothbay Fund Management first reported a position in GSK in Q3 2021 and has held it in 12 quarters since.
  • Boothbay Fund Management's GSK position peaked at $29.7M in Q2 2023.
  • 1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.